THALIDOMIDE DECREASES GELATINASE PRODUCTION BY MALIGNANT B LYMPHOID CELL LINES THROUGH DISRUPTION OF MULTIPLE INTEGRIN-MEDIATED SIGNALING PATHWAYS

Thalidomide decreases gelatinase production by malignant B lymphoid cell lines through disruption of multiple integrin-mediated signaling pathways

Background Thalidomide and its Coffee Table analogs are effective agents in the treatment of multiple myeloma.Since gelatinases (matrix metalloproteinases-2 and -9) play a crucial role in tumor progression, we explored the effect of thalidomide on gelatinase production by malignant B lymphoid cell lines.Design and Methods We investigated the effect

read more

Preference-based measures of health-related quality of life in congenital mobility impairment: a systematic review of validity and responsiveness

Abstract Introduction Mobility impairment is the leading cause of disability in the UK.Individuals with congenital mobility impairments have unique experiences of health, quality of life and adaptation.Preference-based outcomes measures are often used to help inform decisions about healthcare funding and prioritisation, however the applicability an

read more